Susquehanna Fundamental Investments, LLC Morphic Holding, Inc. Transaction History

Susquehanna Fundamental Investments, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$22.23 - $33.37 $386,779 - $580,604	-17,399 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$36.25 - $52.02 $101,935 - $146,280	2,812 Added 19.28%	17,399 $699,000
Q4 2021 Feb 14, 2022	BUY	$43.27 - $65.72 $50,496 - $76,695	1,167 Added 8.7%	14,587 $691,000
Q3 2021 Nov 15, 2021	BUY	$53.61 - $67.5 $354,898 - $446,850	6,620 Added 97.35%	13,420 $760,000
Q2 2021 Aug 11, 2021	BUY	$45.13 - $64.99 $56,863 - $81,887	1,260 Added 22.74%	6,800 $390,000
Q1 2021 May 17, 2021	BUY	$29.77 - $84.85 $164,925 - $470,068	5,540 New	5,540 $351,000
Q4 2020 Feb 16, 2021	SELL	$25.66 - $34.55 $358,264 - $482,387	-13,962 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$22.51 - $30.11 $314,284 - $420,395	13,962 New	13,962 $382,000

4.7M

Ticker MORF
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,477,100
Market Cap $2.19B
Description
Morphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, metabolic diseases, as well as fibrosis and cancer. Its lead product candidates are MORF-057, an a4ß7-specific integrin inhibitor affecting inflammation that is in Phase 1 clinical ...

Get notified when there are updates to the investment portfolio of Susquehanna Fundamental Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Susquehanna Fundamental Investments, LLC with notifications on news.